Literature DB >> 12640293

Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor.

Kazuyuki Mizunuma1, Hideki Ohdan, Hirotaka Tashiro, Yasuhiro Fudaba, Hisao Ito, Toshimasa Asahara.   

Abstract

BACKGROUND: We demonstrated that hepatic stellate cells (HSCs) isolated from rat livers exposed to warm ischemia are significantly contractile when compared with HSCs from intact rat livers. This suggests that ischemia-reperfusion (IR)-induced impairment of sinusoidal microcirculation results, at least in part, from contraction of HSCs.
METHODS: Rho-associated coiled-coil forming protein serine/threonine kinase (ROCK) is one of the key regulators of HSCs motility. Therefore we investigated whether Y-27632, a p160ROCK-specific inhibitor, has beneficial effects on warm IR injury in an in vivo rat partial liver IR model and a rat orthotopic liver transplantation model.
RESULTS: After reperfusion following 90 min of warm ischemia, livers in untreated control rats had persistent congestion and impaired mitochondrial respiration, as demonstrated by increasing deoxy-hemoglobin and reduced cytochrome oxidase contents in the hepatic tissues using in vivo near-infrared spectroscopy. Serum levels of transaminase and endothelin (ET)-1 in these rats were markedly increased 1 hr after reperfusion. In contrast, when Y-27632 (3-30 mg/kg) was administered orally, hepatic tissue contents of deoxy-hemoglobin and cytochrome oxidase rapidly normalized. In such animals, the elevation of serum transaminase levels, but not that of ET-1 levels, was significantly suppressed. This is consistent with in vitro data demonstrating that Y-27632 causes HSCs to undergo relaxation even in the presence of ET-1. Moreover, in a rat orthotopic liver transplantation model, Y-27632 pretreatment dramatically improved the survival of recipients with liver grafts subjected to 45 min of warm ischemia.
CONCLUSIONS: Y-27632 attenuates IR-induced hepatic microcirculation disruption by inhibiting contraction of HSCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640293     DOI: 10.1097/01.TP.0000052593.16876.AF

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.

Authors:  Hirotaka Tashiro; Shintaro Kuroda; Yoshihiro Mikuriya; Hideki Ohdan
Journal:  Surg Today       Date:  2014-09       Impact factor: 2.549

2.  Nilotinib protects the murine liver from ischemia/reperfusion injury.

Authors:  Lee M Ocuin; Shan Zeng; Michael J Cavnar; Eric C Sorenson; Zubin M Bamboat; Jonathan B Greer; Teresa S Kim; Rachel Popow; Ronald P DeMatteo
Journal:  J Hepatol       Date:  2012-05-26       Impact factor: 25.083

3.  Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.

Authors:  Q Zhou; M Hennenberg; J Trebicka; K Jochem; L Leifeld; E Biecker; T Sauerbruch; J Heller
Journal:  Gut       Date:  2006-02-21       Impact factor: 23.059

Review 4.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.